Ignite Creation Date:
2025-12-24 @ 2:33 PM
Ignite Modification Date:
2025-12-25 @ 5:49 PM
Study NCT ID:
NCT00337259
Status:
TERMINATED
Last Update Posted:
2016-02-17
First Post:
2006-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine for Marginal Zone Lymphoma
Sponsor:
Asan Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-14
First Submit QC Date:
None
Study First Post Date:
2006-06-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-13
Last Update Post Date:
2016-02-17
Last Update Post Date Type:
ESTIMATED